ArticleHaematologica2024
Safety and efficacy of flumatinib as later-line therapy in patients with chronic myeloid leukemia.
Yunfan Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it